Date
Launching a Companion Diagnostic
Research & Development Through Commercialization
NeoGenomics shares its experience with developing and deploying diagnostics for use in clinical trials through our Pharma Services Division. We highlight our experience developing CDx through different regulatory pathways with the pros and cons associated with the different technology and platform choices available. Case studies are discussed highlighting our expertise and know-how with enabling day-one commercial launches.

About
Scott Reid, PhD, MBA
Scott Reid, PhD, MBA